Bank of America’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-35,100
| Closed | -$1.9M | – | 7421 |
|
|
2025
Q3 | $1.9M | Buy |
35,100
+1,100
| +3% | +$62.9K | ﹤0.01% | 4859 |
|
|
2025
Q2 | $1.87M | Hold |
34,000
| – | – | ﹤0.01% | 4835 |
|
|
2025
Q1 | $2.4M | Sell |
34,000
-32,600
| -49% | -$2.19M | ﹤0.01% | 4519 |
|
|
2024
Q4 | $4.38M | Buy |
66,600
+12,000
| +22% | +$804K | ﹤0.01% | 3721 |
|
|
2024
Q3 | $3.84M | Hold |
54,600
| – | – | ﹤0.01% | 3983 |
|
|
2024
Q2 | $4.5M | Sell |
54,600
-271,400
| -83% | -$22.6M | ﹤0.01% | 3709 |
|
|
2024
Q1 | $28.5M | Buy |
326,000
+292,000
| +859% | +$26.1M | ﹤0.01% | 1947 |
|
|
2023
Q4 | $3.28M | Buy |
+34,000
| New | +$3.01M | ﹤0.01% | 3921 |
|
|
2023
Q3 | – | Sell |
-23,900
| Closed | -$2.07M | – | 7777 |
|
|
2023
Q2 | $2.07M | Sell |
23,900
-86,900
| -78% | -$8.18M | ﹤0.01% | 4204 |
|
|
2023
Q1 | $10.8M | Buy |
110,800
+35,500
| +47% | +$3.68M | ﹤0.01% | 2752 |
|
|
2022
Q4 | $7.79M | Hold |
75,300
| – | – | ﹤0.01% | 2928 |
|
|
2022
Q3 | $6.38M | Buy |
75,300
+47,500
| +171% | +$4.23M | ﹤0.01% | 3079 |
|
|
2022
Q2 | $2.3M | Buy |
+27,800
| New | +$2.21M | ﹤0.01% | 4180 |
|
|
2022
Q1 | – | Sell |
-1,700
| Closed | -$150K | – | 8271 |
|
|
2021
Q4 | $150K | Buy |
1,700
+200
| +13% | +$16.5K | ﹤0.01% | 6657 |
|
|
2021
Q3 | $116K | Hold |
1,500
| – | – | ﹤0.01% | 6639 |
|
|
2021
Q2 | $125K | Hold |
1,500
| – | – | ﹤0.01% | 6388 |
|
|
2021
Q1 | $113K | Sell |
1,500
-23,900
| -94% | -$1.95M | ﹤0.01% | 6334 |
|
|
2020
Q4 | $2.23M | Sell |
25,400
-28,300
| -53% | -$2.24M | ﹤0.01% | 3859 |
|
|
2020
Q3 | $4.08M | Buy |
53,700
+1,000
| +2% | +$101K | ﹤0.01% | 3097 |
|
|
2020
Q2 | $6.5M | Sell |
52,700
-40,800
| -44% | -$4.05M | ﹤0.01% | 2620 |
|
|
2020
Q1 | $7.9M | Buy |
93,500
+15,500
| +20% | +$1.34M | ﹤0.01% | 2256 |
|
|
2019
Q4 | $6.59M | Buy |
78,000
+37,500
| +93% | +$2.83M | ﹤0.01% | 2973 |
|
|
2019
Q3 | $2.73M | Sell |
40,500
-92,200
| -69% | -$7.1M | ﹤0.01% | 3780 |
|
|
2019
Q2 | $11.4M | Buy |
+132,700
| New | +$11.4M | ﹤0.01% | 2408 |
|
|
2019
Q1 | – | Sell |
-49,700
| Closed | -$4.23M | – | 7108 |
|
|
2018
Q4 | $4.23M | Sell |
49,700
-75,900
| -60% | -$7.22M | ﹤0.01% | 3174 |
|
|
2018
Q3 | $12.2M | Buy |
125,600
+25,600
| +26% | +$2.56M | ﹤0.01% | 2290 |
|
|
2018
Q2 | $9.42M | Buy |
+100,000
| New | +$8.76M | ﹤0.01% | 2536 |
|
|
2018
Q1 | – | Sell |
-451,100
| Closed | -$40.2M | – | 7107 |
|
|
2017
Q4 | $40.2M | Buy |
451,100
+440,400
| +4,116% | +$38.3M | 0.01% | 1241 |
|
|
2017
Q3 | $996K | Buy |
+10,700
| New | +$945K | ﹤0.01% | 4510 |
|
|
2017
Q2 | – | Sell |
-19,800
| Closed | -$1.74M | – | 6938 |
|
|
2017
Q1 | $1.74M | Sell |
19,800
-42,100
| -68% | -$3.75M | ﹤0.01% | 3992 |
|
|
2016
Q4 | $5.13M | Buy |
61,900
+29,700
| +92% | +$2.55M | ﹤0.01% | 2908 |
|
|
2016
Q3 | $2.98M | Buy |
32,200
+7,200
| +29% | +$678K | ﹤0.01% | 3301 |
|
|
2016
Q2 | $1.95M | Sell |
25,000
-84,300
| -77% | -$7.17M | ﹤0.01% | 3645 |
|
|
2016
Q1 | $9.02M | Buy |
109,300
+104,300
| +2,086% | +$8.49M | ﹤0.01% | 2234 |
|
|
2015
Q4 | $524K | Sell |
5,000
-10,000
| -67% | -$1.04M | ﹤0.01% | 4793 |
|
|
2015
Q3 | $1.58M | Sell |
15,000
-31,600
| -68% | -$4.22M | ﹤0.01% | 3967 |
|
|
2015
Q2 | $6.37M | Sell |
46,600
-33,000
| -41% | -$4.09M | ﹤0.01% | 2345 |
|
|
2015
Q1 | $9.92M | Buy |
79,600
+78,500
| +7,136% | +$8.32M | ﹤0.01% | 1880 |
|
|
2014
Q4 | $99K | Sell |
1,100
-1,700
| -61% | -$141K | ﹤0.01% | 5890 |
|
|
2014
Q3 | $202K | Sell |
2,800
-1,100
| -28% | -$72.3K | ﹤0.01% | 5377 |
|
|
2014
Q2 | $243K | Sell |
3,900
-16,400
| -81% | -$991K | ﹤0.01% | 5370 |
|
|
2014
Q1 | $1.39M | Buy |
20,300
+15,400
| +314% | +$1.13M | ﹤0.01% | 3579 |
|
|
2013
Q4 | $345K | Sell |
4,900
-24,000
| -83% | -$1.63M | ﹤0.01% | 5097 |
|
|
2013
Q3 | $2.08M | Buy |
28,900
+11,100
| +62% | +$738K | ﹤0.01% | 3237 |
|
|
2013
Q2 | $993K | Buy |
+17,800
| New | +$1.11M | ﹤0.01% | 4048 |
|
Other funds holding BMRN
VCM
VPM
Bank of America's BMRN Position: Q1 2026 in Review
Bank of America increased its BioMarin Pharmaceuticals (BMRN) stake by 8.4% in Q1 2026, buying an estimated $4.22M and bringing the position to 936,951 shares worth $52.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1550.
Bank of America first reported a position in BMRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $342M in Q1 2023. 556 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- Bank of America held 936,951 shares of BioMarin Pharmaceuticals worth $52.9M as of Q1 2026.
- Bank of America bought 72,439 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $4.22M.
- BioMarin Pharmaceuticals made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #1550 holding.
- Bank of America first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Bank of America's BioMarin Pharmaceuticals position peaked at $342M in Q1 2023.
- 556 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.